Onglyza approved in EU in combination with other diabetes drugs

10/5/2009 | Google

European regulators approved AstraZeneca and Bristol-Myers Squibb's diabetes medicine Onglyza as a combination treatment with metformin or two other standard drugs for Type 2 diabetes. The companies plan to roll out Onglyza in the EU by the end of the year.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA